Skip to main content

Medicis Pharmaceutical Corp (NYSE:MRX) Investor Files Lawsuit Over Alleged Breaches Of Fiduciary Duties In Connection With The Proposed Takeover by Valeant Pharmaceuticals International

  • If you purchased shares of the Medicis Pharmaceutical Corp (NYSE:MRX) prior to August 31, 2012, and currently hold any of those NYSE:MRX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

Sept. 28, 2012 (Shareholders Foundation) -- An investor in shares of Medicis Pharmaceutical Corp (NYSE:MRX) filed a lawsuit against directors in effort to stop the proposed takeover at $44.00 per NYSE:MRX share. On September 3, 2012, Valeant Pharmaceuticals International, Inc. and Medicis Pharmaceutical Corporation announced that they have entered into an agreement under which Valea...



You must register (for free) or login to view the entire case.